Navigation Links
Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March
Date:4/17/2015

New York, New York (PRWEB) April 17, 2015

Testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) that allege this class of prescription medications increases the likelihood that a man will suffer a heart attack, stroke or other life-threatening cardiovascular event continue to mount in a multidistrict litigation underway in U.S. District Court, Northern District of Illinois. According to an updated Statistics Report issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on April 15th, 1,382 cases are now pending in the proceeding. This indicates that 210 new testosterone lawsuits have been filed in the Northern District of Illinois since the Panel issued its previous report on March 16th, when 1,172 cases were noted. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

“Our Firm is representing clients who have filed testosterone claims in this proceeding, and we continue to receive inquiries from others who were allegedly harmed by testosterone replacement therapy. We do not find it surprising that new cases are being filed in this litigation every month,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who allegedly experienced dangerous cardiovascular side effects due to low testosterone treatments.

Testosterone Litigation

According to court documents, millions of men have allegedly used testosterone replacement therapies to combat symptoms typically associated with ageing, even though the medications are only approved to treat hypogonadism, a condition in which levels of the hormone drop due to an underlying injury or illness. The federal testosterone litigation underway in Illinois was established by the JPML in June 2014, and initially included only about four dozen cases. The Panel’s June 6th Order noted that all of the actions had been filed in the wake of the U.S. Food & Drug Administration’s (FDA) January 31, 2014 announcement that it was reviewing the cardiovascular risks allegedly associated with testosterone therapy.* On March 3, 2015, the FDA updated its alert, and ordered the manufacturers of prescription testosterone treatments to add new information to their labels regarding the drugs’ potential to increase a patient’s risk for heart attacks and strokes. The alert also noted that the labels would be modified to make it clear that such therapy had not been shown safe and effective for relieving symptoms associated with age-related drops in testosterone.

Court records indicate that all of the testosterone lawsuits pending in the federal litigation were filed on behalf of men who allegedly experienced heart attacks, strokes, blood clots and other cardiovascular events due to their use of the medications. The claims accuse the drugs’ manufacturers of failing to adequately warn patients of these risks, and of wrongly marketing their testosterone therapies as appropriate treatments for low libido, muscle loss, fatigue and other symptoms commonly associated with male aging.

Men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism or other serious cardiovascular events due to their use of low testosterone therapy may be eligible for compensation for medical bills, lost wages and other injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.testosteronelawsuithub.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/testosterone-stroke/prweb12662736.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Court Overseeing Federal Testosterone Lawsuits Issues New Amended Order Governing Service of Process
2. Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group
3. Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference
4. Bernstein Liebhard LLP Reacts to New Analysis Suggesting Testosterone Therapy is Often Inappropriately Prescribed
5. New Case List Issued For Federal Testosterone Lawsuits Indicates Filings Have Surpassed 300
6. Testosterone Lawsuit Parties File New Joint Status Report in Federal Multidistrict Litigation
7. New Report Details Mounting Testosterone Lawsuit Filings in Federal Litigation Where Bernstein Liebhard LLP Represents a Number of Plaintiffs
8. Testosterone Lawyers at Bernstein Liebhard LLP Comment on Issuance of New Deposition Protocol Governing Federal Testosterone Lawsuits
9. Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation
10. NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks
11. Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2018)... RATON, Fla. (PRWEB) , ... December 06, 2018 ... ... those unable to cope with day-to-day life, there are alternative solutions. M.D.-formulated Relaxium ... , Relaxium Calm ’s main ingredient is Sensoril®, an extract of the ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... one of the first plastic surgery practices in Houston to offer the BodyTitePRO ... bringing his patients an innovative range of surgical and noninvasive techniques to improve ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Strategic Resourcing, and Consulting services, announced its new office location in Paris, France ... organic growth of clinical trial operations in Europe and additional in-country personnel. , ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... Insurance Group (HM). In this role, he will be responsible for the executive ... strategy. , “We conducted an extensive, nationwide search for this position,” Tom Doran, ...
(Date:11/29/2018)... ... November 29, 2018 , ... Cerebral ... treat chronic pain without opiates. This new and unique approach to the pathophysiology ... chronic pain for both children and adults. , According to CPARF’s Medical ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... ... Two women with a vision to make the blind see were the ... M.D., Ph.D., and Katherine A. High, M.D., whose work with the RPE65 mutation has ... Health, headquartered in Sioux Falls, South Dakota. , “I want to thank the ...
(Date:12/5/2018)... ... , ... Smart pill device and app developer Pillsy ... the launch of its new user-oriented nutritional supplement subscription service Stride Nutrition ... technology to enhance users’ control of, and adherence to, nutritional supplement regimens. , ...
(Date:11/29/2018)... ... November 29, 2018 , ... ... health records (EHR) technology for acute care, post-acute care, and long-term care facilities, ... Support and Service. Hynds will lead Cantata Health’s highly regarded customer support team ...
Breaking Medicine Technology: